Monday, Jun 3, 2024 · SEC filings
What the smart money revealed on Jun 3
811 insider filings came in. We hid 59 planned (10b5-1) sellers and 605 people whose filings were routine, like grants and tax withholding.
3 insiders at aTYR Pharma (ATYR) bought $133K of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
Bio Essence (BIOE) CEO Yin Yan bought $2.5M
5M shares on the open market. Not a grant or an option exercise.
Life Time Group (LTH) Founder and CEO Bahram Akradi bought $654K
39,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.
FTAI Aviation (FTAI) Director Martin Tuchman bought $546K
25,000 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.
Altus Power (AMPS) Co-founder Gregg Felton bought $322K
82,576 shares on the open market. Not a grant or an option exercise.
CCC Intelligent Solutions (CCC) Director Christopher Egan sold $476M
Not marked as a planned 10b5-1 sale. Sold 20% of the shares they held directly. Still holds 164.32M shares.
Apple (AAPL) Director Arthur Levinson sold $14.4M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 4.36M shares.
Tandem Diabetes Care (TNDM) Director Dick Allen sold $258K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 43 more real buys
Show 68 more real sales
13F season
Holdings as of Mar 31, 2024 were due May 15
50 funds have filed. 49 filed for the quarter before.
Biggest real insider buys, May 28–Jun 3
Open-market buys by officers and directors, filed in the 7 days up to Jun 3.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.